STOCK TITAN

Charlie S Holdin Stock Price, News & Analysis

CHUC OTC

Welcome to our dedicated page for Charlie S Holdin news (Ticker: CHUC), a resource for investors and traders seeking the latest updates and insights on Charlie S Holdin stock.

Charlie's Holdings, Inc. (CHUC) delivers innovative vapor products and energy drinks through advanced formulations and strategic regulatory compliance. This news hub provides investors and industry observers with essential updates about the company’s operational developments, product innovations, and market strategies.

Access authoritative information on CHUC’s progress in nicotine substitute technologies, including Metatine-based products and SPREE BAR vapor systems. Stay informed about international distribution partnerships, FDA compliance milestones, and advancements in age-gating technologies designed to promote responsible consumption.

The repository features official announcements regarding financial results, product launches, regulatory engagements, and strategic initiatives across 90+ countries. Content is curated to support informed decision-making without speculative commentary.

Bookmark this page for direct access to verified updates about Charlie’s Holdings’ dual focus on premium vaping solutions and energy drink innovations. Regularly updated to reflect the company’s evolving position in consumer product markets.

Rhea-AI Summary

Charlie's Holdings (OTCQB: CHUC) appointed Dr. Edward Carmines to its Board of Directors. Carmines, a regulatory expert, has experience with the FDA, including successful PMTA and MRTPA applications. This appointment is timely, as the FDA has issued numerous marketing denial orders affecting e-cigarette products. The leadership hopes Carmines' expertise will enhance the Company's existing PMTAs currently under review. His previous successes include being the architect behind a notable MRTP marketing order at 22nd Century Group.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.73%
Tags
management
-
Rhea-AI Summary

Charlie's Holdings, Inc. (OTCQB:CHUC) reported its Q3 2021 financial results, showcasing a 34% increase in revenue to $5.2 million compared to Q3 2020. The company's gross profit rose 31% to $2.9 million, while operating income improved significantly to $0.4 million, reversing a loss of $0.9 million last year. Net income surged to $3.1 million, up from a loss of $6.8 million, aided by a gain in fair value of derivative liabilities. Management highlighted ongoing progress towards uplisting and confidence in PMTA submissions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Charlie's Holdings, Inc. (OTCQB:CHUC) is transitioning to a board with a majority of independent directors, as announced on November 3, 2021. CEO Brandon Stump has resigned to facilitate this transition, while remaining the largest shareholder after investing an additional $3 million. Inside directors Keith Stump and David Allen are also resigning. The company aims to uplist to a national securities exchange and plans to appoint new independent directors by January 1, 2022. The executive management team, led by COO Ryan Stump and President Henry Sicignano, is recognized for their expertise and is expected to drive future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Charlie's Holdings, Inc. (OTCQB:CHUC) announced that its Premarket Tobacco Product Applications (PMTAs) for its top-selling e-liquids have passed the FDA's filing review and entered the Substantive Review phase. This positions the company favorably compared to competitors, as over 992,000 flavored e-cigarette products received Marketing Denial Orders, while Charlie's submissions include over $5 million in scientific data and studies aimed at proving public health benefits. The company anticipates a competitive advantage leading to increased sales and market share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.05%
Tags
none
-
Rhea-AI Summary

Charlie's Holdings, Inc. (OTCQB: CHUC) reported a 31% revenue increase to $5.4 million for Q2 2021, alongside an operating loss reduction of 78% to $168,000. The gross profit rose 9% to $2.6 million. Key advancements included the FDA's PMTA submission for top-selling e-liquids and the launch of Pachamama Disposables. The company aims for profitability, supported by a solid balance sheet and strong market momentum.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
none
-
Rhea-AI Summary

Charlie's Holdings, Inc. (OTCQB:CHUC) announced its uplisting from the OTC Pink Market to the more prestigious OTCQB Venture Market, effective August 3, 2021. This shift enhances the company's visibility and credibility in capital markets. Charlie's aims to appeal to a broader investor base and move closer to uplisting on a national exchange. The company is also navigating the FDA's Premarket Tobacco Application process and has projected revenue growth for 2021. Improved financials and compliance with OTCQB standards signify a positive trajectory for the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.8%
Tags
none
Rhea-AI Summary

Charlie's Holdings, Inc. (OTC Pink:CHUC) announced a 1-for-100 reverse stock split effective June 16, 2021, with necessary approvals from FINRA. The share count will reduce from approximately 20.3 billion to 203.2 million, enhancing capital markets appeal and supporting a future uplisting to a national exchange. The split aims to attract a broader investor base, and following the split, shares will temporarily trade as CHUCD for 20 days. The company anticipates growth in revenue for FY 2021 compared to 2020, supported by recent stock purchases totaling $3 million by executives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.63%
Tags
none
-
Rhea-AI Summary

Charlie's Holdings, Inc. (OTC PINK:CHUC) announced its best-selling e-liquids have received inclusion on the FDA's list of deemed new tobacco products, following timely submission of a Premarket Tobacco Product Application (PMTA). This marks a significant milestone as Charlie's is one of the few companies to pass the FDA's filing phase and enter the Substantive Review phase. Charlie's commitment to regulatory compliance is expected to provide a competitive edge, potentially boosting sales, profits, and market share, while other firms face product withdrawals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.89%
Tags
none
-
Rhea-AI Summary

Charlie's Holdings, Inc. (OTC PINK:CHUC) reported significant improvements for Q1 2021, with revenue rising 3% to $4,361,000 from Q4 2020, despite a 1% year-over-year decline. Gross profit increased more than 14% to $2,418,000, with gross margin expanding to 55%. Operating loss decreased by 95% to $229,000. The company closed a $3 million capital raise and introduced the new Pachamama Disposables™ line. Charlie's PMTA is under substantive review with the FDA, providing a potential competitive edge in the premium e-liquid market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.83%
Tags
none
Rhea-AI Summary

Charlie's Holdings, Inc. (OTC PINK:CHUC) announced the appointment of Matt Montesano as Chief Financial Officer, effective May 10, 2021. Montesano previously served as CFO for Charlie's Chalk Dust and has experience in financial strategy and SEC reporting. David Allen, the former CFO, will transition to a position on the Board of Directors, leveraging his 24 years of public company experience. The leadership change aims to strengthen management as the company navigates growth in the e-cigarette and CBD markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.27%
Tags
management

FAQ

What is the current stock price of Charlie S Holdin (CHUC)?

The current stock price of Charlie S Holdin (CHUC) is $0.09 as of May 12, 2025.

What is the market cap of Charlie S Holdin (CHUC)?

The market cap of Charlie S Holdin (CHUC) is approximately 10.9M.
Charlie S Holdin

OTC:CHUC

CHUC Rankings

CHUC Stock Data

10.87M
91.15M
62.72%
4.84%
Tobacco
Consumer Defensive
Link
United States
Costa Mesa